This brand name is authorized in United States. It is also authorized in Australia, Canada, Ecuador, Estonia, Ireland, Italy, Malta, New Zealand, South Africa, Spain, Turkey, UK.
The drug NAPROSYN contains one active pharmaceutical ingredient (API):
1
|
UNII
57Y76R9ATQ - NAPROXEN
|
|
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| NAPROSYN Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AE02 | Naproxen | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives |
| M02AA12 | Naproxen | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 1614Y, 1615B, 1674D, 5176K, 5178M, 5179N, 5345H, 5347K, 5348L |
| CA | Health Products and Food Branch | 02162415, 02162423, 02162466 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 5.413-4-01-12 |
| EE | Ravimiamet | 1243336, 1747728, 1774188, 1774874 |
| ES | Centro de información online de medicamentos de la AEMPS | 56267 |
| GB | Medicines & Healthcare Products Regulatory Agency | 18353, 18407 |
| IE | Health Products Regulatory Authority | 37157, 37169 |
| IT | Agenzia del Farmaco | 023177138, 023177189, 023177215 |
| MT | Medicines Authority | AA1067/00101 |
| NZ | Medicines and Medical Devices Safety Authority | 1924, 1925 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699514030577, 8699514037491, 8699514040002, 8699514130123, 8699514340089, 8699514890058 |
| US | FDA, National Drug Code | 0121-0899, 0121-1798, 0121-2697, 69437-316, 71511-701, 80425-0048, 80425-0049, 80425-0050, 80425-0051 |
| ZA | Health Products Regulatory Authority | 27/3.1/0067 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.